Physician profile
Michael Pasternac
NPI 1366442824
$6,199.15
in general payments reported to CMS, 2019-2025
21 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $382 · 2021: $1,528 · 2022: $1,462 · 2023: $392 · 2024: $624 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534 · Travel and Lodging: $47.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.40 |
| Travel and Lodging | $47.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,604.46 | 2019-2025 | Salvation, Hoffmann, Valor |
| Southern Edge Orthopaedics, INC. | $1,297.00 | 2019-2022 | |
| Paragon 28, INC. | $1,202.88 | 2021 | |
| Smith+Nephew, INC. | $738.94 | 2019-2024 | Evos Mini, Maverick, Ilizarov |
| Treace Medical Concepts, INC. | $382.65 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $204.64 | 2019-2020 | |
| Organogenesis INC. | $159.21 | 2021-2025 | Nushield, Puraply Wound Matrix |
| Royal Biologics, INC. | $138.27 | 2020 | |
| Tei Medical INC. | $112.45 | 2019 | |
| Access Pro Medical, LLC | $94.71 | 2025 | Matriderm |
| Embody, INC. | $47.50 | 2022 | |
| Integra Lifesciences Corporation | $38.92 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $30.49 | 2022 | |
| Depuy Synthes Sales INC. | $27.97 | 2025 | N/A |
| Aroa Biosurgery Incorporated | $23.76 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $22.11 | 2020 | |
| Merck Sharp & Dohme LLC | $19.88 | 2019 | |
| Kci USA, INC. | $19.40 | 2021 | |
| Arthrex, INC. | $18.00 | 2023 | |
| Medtronic, INC. | $15.91 | 2023 | Venaseal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pasternac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.